Palantir Technologies
PLTR
$160.39
-4.52%
Palantir Technologies is an artificial intelligence, analytics, and automated decision-making software company whose Foundry platform serves commercial enterprises and whose Gotham platform serves government and defense clients, operating within the Software - Infrastructure industry. Palantir occupies a distinctive position as a high-end, mission-critical data-integration platform vendor with deep Western-allied government relationships and an expanding commercial footprint, rather than a commoditized SaaS provider. The current investor narrative is dominated by the tension between extraordinary fundamental acceleration — U.S. revenue reportedly up 119% with commercial revenue surpassing government revenue for the first time — and an extreme valuation that management's own Q3 results failed to fully reassure, as flat remaining performance obligations and a sharp slowdown in total contract value growth raised questions about forward sales momentum. This debate has been sharpened by a violent October-to-November drawdown in AI software multiples, with sell-side voices explicitly flagging valuation and governance risk even as bulls argue the commercial traction justifies dollar-cost-averaged exposure.…
PLTR
Palantir Technologies
$160.39
Related headlines
Investment Opinion: Should I buy PLTR Today?
Rating: Hold, with a constructive bias toward accumulating on weakness. The core thesis is that Palantir's business quality is genuinely elite — 95.87% revenue growth, 46.89% operating margin, $4.05 billion TTM free cash flow, and a debt-free balance sheet — but the current $167.99 price already embeds years of flawless execution, and the flat RPO disclosure is the first credible crack in the growth narrative. The analyst consensus of "buy" (22 Buy / 9 Hold / 2 Sell, 1.85 recommendation mean) with an average target of $222.25 implies roughly +32.3% upside, but that target sits against a 3.4x spread from $80 to $273, signaling genuine disagreement rather than conviction.
Supporting evidence is strong on fundamentals and weak on price. Revenue accelerated from +84.7% YoY in Q1 to +92.8% in Q2 to +95.87% in Q3, with commercial revenue ($1.168 billion) surpassing government ($1.146 billion) for the first time and U.S. revenue reportedly up 119%. Operating margin expanded from 1.33% in Q4 2024 to 46.89% in Q3 2026 while gross margin held stable at 83.43%, proving opex discipline rather than pricing is driving leverage. Free cash flow of $4.054 billion TTM converts at 99.3% of operating cash flow, and debt-to-equity of 0.031 with a 7.11 current ratio means growth is fully self-funded. But the price is the problem: 94.1x PS, 257.6x trailing PE, 249.5x EV/EBITDA, and 197.3x price-to-cash-flow represent a 275-840% premium to high-growth software peers at 10-25x sales, and even the 66.2x forward PE requires earnings to roughly quadruple.
The biggest risks that could invalidate the thesis are (1) forward bookings deterioration — flat RPO and slowing total contract value growth proving to be the leading edge of deceleration rather than a timing quirk; (2) multiple compression as the AI software rotation that began October 16 continues, with the stock already down 16.41% in one month versus SPY's -2.26% and a beta of 1.61 amplifying any market drawdown; and (3) governance concerns flagged explicitly by sell-side commentary. This Hold would upgrade to Buy on a pullback toward the $106-$120 support zone (a 29-37% decline) or on evidence that RPO and total contract value growth re-accelerate in Q4, and would downgrade to Sell if revenue growth decelerates below 60% or if the stock breaks decisively below the $154.99 November swing low. Verdict: the stock is overvalued relative to peers and its own 2022-2023 PS band of 26-62x, but fairly valued relative to its own recent history (PS has ranged from 26.4x to 365.1x), making this a high-quality business at a demanding price rather than a broken one.
Sign up to view all
PLTR 12-Month Price Forecast
Palantir is a genuinely exceptional business trading at a genuinely exceptional price, and the 12-month outlook hinges on whether the 95.87% growth rate is durable or whether flat RPO is the leading edge of deceleration. The fundamentals — accelerating revenue, 46.89% operating margins, $4.05 billion TTM free cash flow, and a debt-free balance sheet — argue the business deserves a premium, but 94.1x PS and 257.6x trailing PE mean the stock discounts years of perfection, and the 66.2x forward PE requires earnings to roughly quadruple. The 50% base case reflects a gradual deceleration toward 50-70% growth with a modest multiple compression, producing a range-bound year between $155 and $222, while the 25% bull case requires RPO to re-accelerate and the AI rotation to reverse, and the 25% bear case reflects a de-rating toward historical PS norms and the $80-$120 zone. I would upgrade to bullish on a pullback toward the $106-$120 support zone or on evidence that RPO and total contract value growth re-accelerate in Q4, and would downgrade to bearish if revenue growth decelerates below 60% or if the stock breaks decisively below $154.99. With a 1.61 beta and a 48.22% observed maximum drawdown, position sizing matters as much as direction.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Palantir Technologies's 12-month outlook, with a consensus price target around $223.43 and implied upside of +39.3% versus the current price.
Average Target
$223.43
33 analysts
Implied Upside
+39.3%
vs. current price
Analyst Count
33
covering this stock
Price Range
$80 - $273
Analyst target range
Coverage is broad and institutional, with 28 analysts and a distribution of 22 Buy, 9 Hold, and 2 Sell, yielding a consensus recommendation of "buy" and a recommendation mean of 1.85 (where 1.0 is a strong buy). The average target price of $222.25 implies roughly +32.3% upside from the current $167.99, a notably bullish consensus that stands in sharp contrast to the stock's -16.41% one-month performance and -14.15% relative weakness versus SPY. The consensus is clearly bullish, but the recent institutional ratings flow shows conviction is static rather than improving: the November 3-4 updates from Barclays (Overweight), Morgan Stanley (Equal Weight), Truist (Buy), DA Davidson (Buy), Rosenblatt (Buy), RBC (Underperform), Cantor Fitzgerald (Neutral), Citigroup (Buy), and Piper Sandler (Overweight) were all reiterations with no upgrades or downgrades, suggesting analysts are holding their ground through the volatility rather than adding to the thesis. The target range is exceptionally wide — $80.00 low to $273.00 high, a 3.4x spread — which signals genuine disagreement about the terminal growth and multiple rather than consensus complacency. The $273 high target implies sustained ~96% growth, further margin expansion, and multiple durability near current levels, effectively assuming the AI commercial land-grab continues unabated; the $80 low target implies a severe de-rating toward historical PS norms and/or material growth deceleration, consistent with the bearish "sell before it drops 57-60%" commentary circulating in the press. The wide dispersion, combined with the static rating pattern and the stock's 1.61 beta, argues for treating the consensus target as a directional signal rather than a precise price objective, and for sizing positions to withstand a retest of the $106-$120 support zone.
Bulls vs Bears: PLTR Investment Factors
The bull case currently rests on stronger fundamental evidence: 95.87% revenue growth, 46.89% operating margins, $4.05 billion TTM free cash flow, and a debt-free balance sheet are objectively elite and accelerating. However, the bear case carries more weight on the price paid — a 94.1x PS and 257.6x trailing PE mean the stock discounts years of perfection, and the flat RPO disclosure is the first credible crack in the growth narrative. The single most important tension is whether the 96% growth rate is durable or whether the flat RPO and slowing total contract value growth are the leading edge of deceleration; if growth merely decelerates to 50-60%, the multiple compresses violently even as the business remains excellent. With a 1.61 beta, a 48% observed drawdown, and a 3.4x analyst target spread, this is a high-conviction-either-way name where position sizing matters as much as direction. Net, the fundamentals favor the bulls, but the valuation and forward-sales signals give the bears a legitimate near-term edge.
Bullish
- Revenue growth accelerating at rare scale: Q3 2026 revenue of $2.313 billion grew 95.87% year-over-year, accelerating from Q2's +92.8% and Q1's +84.7%, with sequential growth of roughly 18-19% per quarter. This cadence implies a run-rate approaching $9.3 billion annualized, a pace almost unheard of at this revenue scale.
- Commercial revenue now exceeds government: Commercial revenue reached $1.168 billion versus government's $1.146 billion, the first time commercial has led — a symbolic threshold showing enterprise AI adoption, not just defense budgets, is the incremental growth engine. U.S. revenue reportedly rose 119%, validating the land-grab thesis.
- Operating leverage driving margin explosion: Q3 operating margin hit 46.89% and net margin 48.76%, versus 33.30% and 40.27% in Q3 2025 and just 1.33% operating margin in Q4 2024. Gross margin held stable at 83.43%, meaning opex discipline — not pricing — is doing the heavy lifting, a highly repeatable dynamic.
- Fortress balance sheet and elite cash generation: Debt-to-equity is just 0.031, current ratio 7.11, and $3.65 billion in cash against zero interest expense. TTM free cash flow of $4.054 billion with Q3 FCF at 99.3% of operating cash flow confirms growth is fully self-funded.
Bearish
- Extreme valuation leaves no margin for error: Trailing PE is 257.6x, PS 94.1x, EV/EBITDA 249.5x, and price-to-cash-flow 197.3x — a PS premium of roughly 275-840% versus high-growth software peers trading at 10-25x sales. Even the forward PE of 66.2x requires earnings to roughly quadruple, so the entire thesis rests on flawless delivery.
- Flat RPO signals forward sales stall: Management's own Q3 results showed flat remaining performance obligations and a sharp slowdown in total contract value growth, which triggered the post-earnings selloff. These are the leading indicators of future revenue, so deceleration here directly threatens the 96% growth that justifies the multiple.
- Severe momentum breakdown and relative weakness: The stock is down 16.41% in one month versus SPY's -2.26%, a -14.15% relative underperformance, with a 48.22% maximum drawdown from peak. The one-month decline against a +25.38% six-month gain signals distribution rather than a healthy consolidation.
- Wide analyst dispersion reveals deep disagreement: Targets range from $80 to $273 — a 3.4x spread — and the $80 low implies a 52% downside de-rating toward historical PS norms. All nine recent institutional updates were reiterations with zero upgrades, showing conviction is static, not improving.
PLTR Technical Analysis
Palantir is in a volatile, range-bound consolidation phase rather than a clean trend, with a 1-year price change of -2.41% and a 6-month gain of +25.38% that has been largely given back at the margin. At the current price of $167.99, the stock sits at roughly 57.8% of its 52-week range (low $106.37, high $212.94), positioning it in the middle-upper portion of the band — neither a momentum breakout nor a falling-knife value zone, but a stock digesting a large prior advance. The 48.22% maximum drawdown underscores how sharply this name can retrace even within an intact longer-term uptrend. Recent momentum has deteriorated markedly: the 1-month change is -16.41% versus a 3-month change of only -3.48%, meaning essentially all of the quarterly decline was concentrated in the last four weeks. That divergence — a -16.41% one-month slide against a +25.38% six-month gain — signals a sharp mean-reversion event or distribution phase rather than a trend reversal confirmation, and it has produced severe relative weakness: relative strength versus SPY is -14.15% over one month and -14.68% over one year, even though 6-month relative strength remains a strong +23.25%. The stock is underperforming a flat-to-weak tape (SPY -2.26% over one month), which is a caution flag for near-term holders. Key technical levels are the $212.94 52-week high as overhead resistance and the $106.37 52-week low as the deep support floor, with the recent November swing low near $154.99 acting as the first line of defense. A decisive reclaim of the $200-$213 zone would reassert the uptrend, while a break below $155 would likely open a path toward the $106-$120 region where the June 2026 lows clustered. With a beta of 1.61, Palantir is roughly 61% more volatile than the market, meaning position sizing should be materially smaller than a market-beta equivalent and stop discipline is essential given the observed 48% peak-to-trough drawdown.
Beta
1.61
1.61x market volatility
Max Drawdown
-48.2%
Largest decline past year
52-Week Range
$106-$213
Price range past year
Annual Return
-7.8%
Cumulative gain past year
| Period | PLTR Return | S&P 500 |
|---|---|---|
| 1m | -13.8% | -3.0% |
| 3m | -6.5% | -3.6% |
| 6m | +16.9% | -0.2% |
| 1y | -7.8% | +10.1% |
| ytd | -4.5% | +8.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PLTR Fundamental Analysis
Revenue growth is not merely strong but accelerating at a rate rarely seen at this scale: Q3 2026 revenue reached $2.313 billion, up 95.87% year-over-year, following $1.935 billion in Q2 (+92.8% YoY versus Q2 2025's $1.004 billion) and $1.633 billion in Q1 (+84.7% YoY versus $884 million). The sequential cadence — $1.633B to $1.935B to $2.313B — represents roughly 18-19% quarter-over-quarter growth, and the segment mix has crossed a symbolic threshold with Commercial at $1.168 billion now edging ahead of Government at $1.146 billion, confirming that enterprise AI adoption, not just defense budgets, is the incremental growth engine. This trajectory implies a run-rate approaching $9.3 billion annualized and validates the bull case that Palantir is compounding far faster than legacy software peers, though the reported flat RPO and slowing total contract value growth are the key leading indicators to monitor for deceleration. Profitability has inflected dramatically: Q3 2026 net income was $1.128 billion (a 48.76% net margin) on gross profit of $1.930 billion (83.43% gross margin), with operating income of $1.085 billion (46.89% operating margin) — a staggering expansion from Q3 2025's $476 million net income on a 40.27% margin and Q4 2024's mere $79 million. Gross margin has been remarkably stable in the 82-87% band across the last five quarters (Q1 2026 peaked at 86.78%), indicating pricing power is intact while operating leverage — not gross margin — is doing the heavy lifting, as opex grew far slower than revenue. The balance sheet is fortress-like: debt-to-equity of just 0.031, a current ratio of 7.11, and $3.65 billion in cash at Q3 end against negligible interest expense. Free cash flow is exceptional at $4.054 billion TTM, with Q3 FCF of $1.197 billion representing 99.3% conversion of $1.205 billion operating cash flow, and ROE of 22.0% and ROA of 19.3% confirm high-quality, internally funded growth with no dependence on external financing.
Quarterly Revenue
$2.3B
2026-09
Revenue YoY Growth
+95.9%
YoY Comparison
Gross Margin
83.4%
Latest Quarter
Free Cash Flow
$4.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PLTR Overvalued?
Because Palantir is now solidly profitable (Q3 net income of $1.128 billion), the PE ratio is the appropriate primary metric, and it tells a stark story: the trailing PE is 257.6x while the forward PE is 66.2x, an enormous 74% compression that implies the market is pricing in roughly a quadrupling of earnings over the forward period. Even the forward multiple of 66.2x is rich for any software company, and the PEG ratio of 1.13 is the one metric that looks almost reasonable — but only because the growth rate embedded in the denominator is itself extraordinary. The gap between trailing and forward PE is the single most important number in this valuation: it says the entire bull case rests on earnings delivery, not multiple stability. On every other measure the stock is priced for perfection: PS of 94.1x, EV/Sales of 54.1x, EV/EBITDA of 249.5x, price-to-cash-flow of 197.3x, and price-to-book of 57.0x. Against a software infrastructure sector where high-growth peers typically trade in the 10-25x sales range, Palantir's 94x PS represents a premium of roughly 275-840%, and its 249x EV/EBITDA is multiples of even expensive AI peers. The premium is partially defensible — 96% revenue growth, 83% gross margins, 47% operating margins, and 22% ROE are elite — but the magnitude of the spread means any growth deceleration would compress the multiple violently, which is precisely what the flat RPO disclosure triggered. Historical context is damning on the multiple: Palantir's own PS ratio has ranged from 26.4x (Q4 2022) to 365.1x (Q3 2025), and at 94.1x it sits in the lower-middle of that band but still far above its 2022-2023 levels of 26-62x. Its trailing PE of 257.6x compares with a historical range from negative (2021-2022) through 551x (Q4 2024) down to 66.3x (Q2 2026), and the current reading is elevated but not at the extreme — the market is pricing optimistic but not maximal expectations, leaving room for either relief or further de-rating.
PE
257.6x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 66x~290x
vs. Industry Avg
26.1x
Industry PE ~26.1x*
EV/EBITDA
249.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the gap between reported results and forward visibility. The flat remaining performance obligations and slowing total contract value growth in Q3 are the most concrete warning signs, because the 95.87% revenue growth and 257.6x trailing PE both depend on bookings converting into future revenue. Revenue concentration is a secondary concern — commercial at $1.168 billion only narrowly exceeds government at $1.146 billion, so a single large government contract loss or a commercial pilot failing to scale could dent the trajectory. Finally, the valuation itself is a financial risk: with a forward PE of 66.2x requiring earnings to roughly quadruple, any quarter that misses the implied trajectory — even a good quarter — can trigger outsized multiple compression, as the post-Q3 selloff demonstrated. Market and competitive risks are dominated by valuation compression. At 94.1x PS and 249.5x EV/EBITDA, Palantir trades at a 275-840% premium to high-growth software peers, leaving it acutely exposed to the AI software multiple reversal already underway — the October 16 rotation saw speculative AI names sold while mega-cap tech attracted flows. The 1.61 beta means a broad market drawdown hits Palantir roughly 61% harder, and the -14.15% one-month relative weakness versus SPY confirms it is already leading the sector lower. Competitive and governance risks compound this: sell-side commentary explicitly flags governance concerns alongside valuation, and the 3.4x analyst target spread ($80 to $273) shows genuine disagreement about terminal growth and multiple durability. The worst-case scenario is a growth-deceleration spiral: flat RPO proves to be the leading edge of bookings weakness, Q4 total contract value growth slows further, and the market re-rates the stock toward historical PS norms in the 26-62x range. That path would take the shares toward the $80 analyst low target, a roughly -52% decline from $167.99, and a break below the $154.99 November swing low would likely open the door to the $106-$120 support zone — a -29% to -37% loss. Given the observed 48.22% maximum drawdown, a 40-50% peak-to-trough decline is a realistic, not tail, outcome in an adverse scenario.
FAQ
The most severe risk is valuation compression: at 94.1x sales and 249.5x EV/EBITDA, any growth deceleration triggers outsized multiple contraction, and the flat RPO plus slowing total contract value growth in Q3 is the clearest early warning. Second is momentum and volatility risk — the stock is down 16.41% in one month versus SPY's -2.26%, a -14.15% relative underperformance, with a 1.61 beta that amplifies market drawdowns and a 48.22% observed maximum drawdown showing how violently it can retrace. Third is company-specific execution risk: commercial revenue of $1.168 billion only narrowly exceeds government's $1.146 billion, so losing a large government contract or failing to scale commercial pilots would dent the growth trajectory that justifies the price. Fourth is governance and sentiment risk, which sell-side commentary has explicitly flagged alongside valuation, and which is amplified by a 3.4x analyst target spread from $80 to $273 showing genuine disagreement about terminal growth. Ranked by severity, valuation compression and forward-bookings deterioration are the two that could most quickly turn a 30% drawdown into a 50% one.
The 12-month forecast splits into three scenarios. The base case carries 50% probability with a $155-$222 range, assuming growth decelerates gradually from 95.87% toward 50-70%, operating margin holds in the 44-48% band, and the stock oscillates between the $154.99 November swing low and the $222.25 analyst average. The bull case carries 25% probability with a $222.25-$273 range, requiring RPO and total contract value growth to re-accelerate in Q4, revenue growth to hold near 90%, and the AI software rotation to reverse. The bear case carries 25% probability with an $80-$120 range, in which flat RPO proves to be the leading edge of a bookings slowdown and the multiple re-rates toward historical PS norms of 26-62x. The base case is most likely because fundamentals remain strong enough to defend the stock while valuation and forward-sales signals cap upside; the key assumption is that growth decelerates rather than collapses.
On virtually every standard metric PLTR is overvalued relative to peers and its own history. The trailing PE of 257.6x, PS of 94.1x, EV/EBITDA of 249.5x, price-to-cash-flow of 197.3x, and price-to-book of 57.0x compare with high-growth software peers typically at 10-25x sales, a premium of roughly 275-840%. The one metric that looks almost reasonable is the PEG ratio of 1.13, but only because the growth rate in the denominator is itself extraordinary. The most important number is the gap between the 257.6x trailing PE and the 66.2x forward PE, a 74% compression that implies the market expects earnings to roughly quadruple — meaning the valuation is a bet on earnings delivery, not multiple stability. Historically, Palantir's own PS has ranged from 26.4x in Q4 2022 to 365.1x in Q3 2025, so at 94.1x it sits in the lower-middle of its own band but far above the 26-62x levels of 2022-2023. The market is paying for optimistic but not maximal expectations, which leaves room for either relief or further de-rating.
From a pure risk/reward standpoint, PLTR is a good business at a demanding price rather than an obvious bargain. The bull case is anchored by 95.87% year-over-year revenue growth, a 46.89% operating margin, $4.05 billion in TTM free cash flow, and a debt-to-equity ratio of just 0.031, while 22 of 28 analysts rate it Buy with an average target of $222.25, implying roughly +32.3% upside from $167.99. The downside is equally concrete: at 94.1x sales and 257.6x trailing earnings, the stock trades at a 275-840% premium to high-growth software peers, and the $80 analyst low target implies a roughly -52% decline if the multiple re-rates toward historical norms. The flat remaining performance obligations disclosed in Q3 is the key swing factor, since it is the first credible crack in the forward growth narrative. It is a reasonable buy for long-horizon investors who dollar-cost average and size positions for a potential retest of the $106-$120 zone, but a poor entry for anyone who cannot stomach a 30-50% drawdown.
PLTR is structurally a long-term holding but a treacherous short-term trading vehicle. The long-term case rests on a genuine growth engine — revenue compounding at 95.87% with 46.89% operating margins, $4.05 billion in TTM free cash flow, and a debt-free balance sheet — which rewards patience over multiple years as earnings catch up to the 66.2x forward PE. The short-term case is far less attractive: a 1.61 beta, a 48.22% maximum drawdown, and a -16.41% one-month move against SPY's -2.26% mean near-term entries are exposed to violent swings, and the stock pays no dividend (payout ratio 0) so there is no income cushion while waiting. Earnings visibility is also clouded by flat RPO, which makes quarter-to-quarter trading a bet on sentiment rather than fundamentals. A concrete minimum holding period of three to five years is appropriate, ideally built through dollar-cost averaging and sized so a retest of the $106-$120 support zone would not force a sale.

